Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924924 · ClinicalTrials.gov registry record · NA
Act Healthy! A Controlled Trial of Worksite Health Promotion
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT00924924: Completed NA study, sponsored by University of Missouri-Columbia.
NCT00924924 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00924924, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this project is to determine if a worksite wellness intervention using a theoretically-based self-management model increases confidence for carrying out healthy behaviors and improves health practices of participating employees. The research questions are: 1) does the intervention produce between group differences in behavior self-efficacy and actual health behaviors, 2) are self-efficacy and performance of health behaviors related, and 3) do changes in self-efficacy result in changes in behavior.
Interventions
- BEHAVIORAL Act Healthy!
- BEHAVIORAL Delayed treatment control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT00924924 record still lists
NCT00924924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Act Healthy! is the first listed.
NCT00924924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00924924 about?
NCT00924924 is a clinical study titled "Act Healthy! A Controlled Trial of Worksite Health Promotion". The purpose of this project is to determine if a worksite wellness intervention using a theoretically-based self-management model increases confidence for carrying out healthy behaviors and improves health practices of participating employees. The research questions are: 1) does the intervention pro...
What is the current status of trial NCT00924924?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2009-08. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00924924?
The interventions under investigation include: Act Healthy! (BEHAVIORAL), Delayed treatment control (BEHAVIORAL).
Who is sponsoring clinical trial NCT00924924?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00924924's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia